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Abstract
Background. To identify developmental sub-groups of depressive symptoms during the
second decade of life, a critical period of brain development, using data from a prospective
birth cohort. To test whether childhood intelligence and inflammatory markers are associated
with subsequent persistent depressive symptoms.
Methods. IQ, a proxy for neurodevelopment, was measured at age 8 years. Interleukin 6 (IL-6)
and C-reactive protein, typical inflammatory markers, were measured at age 9 years.
Depressive symptoms were measured six times between 10 and 19 years using the short
mood and feelings questionnaire (SMFQ), which were coded as binary variable and then
used in latent class analysis to identify developmental sub-groups of depressive symptoms.
Results. Longitudinal SMFQ data from 9156 participants yielded three distinct population
sub-groups of depressive symptoms: no symptoms (81.2%); adolescent-onset symptoms
(13.2%); persistent symptoms (5.6%). Lower IQ and higher IL-6 levels in childhood were inde-
pendently associated with subsequent persistent depressive symptoms in a linear, dose–
response fashion, but not with adolescent-onset symptoms. Compared with the group with
no symptoms the adjusted odds ratio for persistent depressive symptoms per S.D. increase
in IQ was 0.80 (95% CI, 0.68–0.95); that for IL-6 was 1.20 (95% CI, 1.03–1.39). Evidence
for an association with IL-6 remained after controlling for initial severity of depressive symp-
toms at 10 years. There was no evidence that IL-6 moderated or mediated the IQ-persistent
depressive symptom relationship.
Conclusions. The results indicate potentially important roles for two distinct biological pro-
cesses, neurodevelopment and inflammation, in the aetiology of persistent depressive symp-
toms in young people.
Introduction
Mood disorders affect about 20% of the population in lifetime and a quarter of all cases of
depression emerge before age 20 (Kessler et al. 2003, 2005). The second decade of life is a crit-
ical period for brain development; decrease in grey matter volume and increase in connectivity
and integrative processing occur during adolescence (Gogtay et al. 2004). These developmental
events are mirrored by a tide of emergent mental disorders such that, excluding neurodegen-
erative disorders of later life, about half of all mental disorders first occur by the mid-teens
(Kessler et al. 2005; Jones, 2013). Distinct trajectories of depressive and anxiety symptoms
emerge during early- to mid-teen age years; persistent and severe symptoms during adoles-
cence and adulthood are associated with markers of altered neurodevelopment such as delayed
motor milestones (Colman et al. 2007). High depressive symptoms during the second decade
of life may represent a vulnerability factor for subsequent major depression (Owens et al.
2014).
Non-specific and transitory elements of depression are common in youth and early adult-
hood, crystallising into a clinical syndrome in some but not all of those who experience them
(Merikangas et al. 2003). Examining depression at a single time point or average levels over
time fails to fully account for population heterogeneity because distinct groups of individuals
can arrive at the same end point via different pathways. Therefore, longitudinal studies of
depressive symptoms over the early-life course including their antecedents and markers for
persistence would be helpful for understanding the causes and mechanisms of depression.
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Compared with a one off measure of psychopathology longitu-
dinal groups derived from repeated measures is less affected by
occasional misreporting or temporary fluctuations in a condition.
Such approach is also more efficient as they maximise use of par-
tial responses to inform group membership.
In this study, we have used longitudinal population-based data
from the Avon Longitudinal Study of Parents and Children
(ALSPAC) birth cohort to identify developmental subgroups of
young people based on self-reported depressive symptoms mea-
sured six times between 10 and 19 years using the Short Mood
and Feelings Questionnaire (SMFQ). We have then examined
risk factors associated with persistent depressive symptoms par-
ticularly focusing on two biological processes, neurodevelopment
and inflammation. Longitudinal studies reporting an association
with lower childhood IQ indicate a neurodevelopmental compo-
nent to adult depression (Zammit et al. 2004; Koenen et al.
2009). We have previously shown that childhood inflammation
is associated with increased risks of depressive and psychotic
symptoms subsequently in early-adulthood (Khandaker et al.
2014a). There is some evidence for a link between inflammation,
neurodevelopment and cognitive function. Both infection
(Khandaker et al. 2013) and immunological genes (Sekar et al.
2016) associated with the risk of psychosis can interfere with neu-
rodevelopment. Inflammation is associated with reduced cogni-
tive performance in experimental studies of healthy volunteers
(Reichenberg et al. 2001; Harrison et al. 2009) and with cognitive
decline in clinical populations at risk of dementia (Iwashyna et al.
2010). Although previous longitudinal studies have reported asso-
ciations between childhood lower IQ, inflammation and depres-
sion in adulthood, it is unclear whether these risk factors are
associated with persistent symptoms. Furthermore, to our knowl-
edge no study has examined the interplay between inflammation
and neurodevelopment with regards to risk of depression.
Using longitudinal population-based data, we have tested the
hypothesis that childhood general intelligence, as measured by
IQ at 8 years, and inflammation, as measured by elevated
serum concentrations of interleukin 6 (IL-6) and C-reactive pro-
tein (CRP) at 9 years, are associated with persistent depressive
symptoms subsequently between age 10 and 19 years independ-
ently of each other. We have explored linearity of association;
the effects of past psychological and behavioural problems, initial
severity of depressive symptoms, and sex difference on the IQ/
inflammation-persistent depressive symptom relationship (see
statistical analysis for rationale and approach). In addition, we
have examined the relationship between IQ and inflammatory
markers. We have tested whether inflammation mediates and/or
moderates the relationship between childhood IQ and subsequent
persistent depressive symptoms.
Methods
Description of cohort and sample
The ALSPAC birth cohort recruited 14 541 pregnant women resi-
dent in county Avon, a geographically defined region in southwest
of England, with expected dates of delivery 1st April 1991 to 31st
December 1992 (http://www.bristol.ac.uk/alspac/) (Boyd et al.
2013). The study website contains details of all available data
through a fully searchable ‘data dictionary’ (http://www.bris.ac.
uk/alspac/researchers/data-access/data-dictionary/). Parents com-
pleted regular postal questionnaires about all aspects of their child’s
health and development from birth. Since age 7, the children
attended an annual assessment clinic during which they participated
in various face-to-face interviews and physical tests.
Groups of depressive symptoms were created using 9156 par-
ticipants who had completed the SMFQ at least once between 10
and 19 years. This approach to sample selection – as opposed to
including only those who had completed the SMFQ at all six time
points – increased representativeness of the sample, sample size
and statistical power. Sample size for the analyses of childhood
IQ (N = 6833) and inflammatory markers (N = 4409) vary as
these childhood measures were completed by different numbers
of people. IQ was assessed on 7354 individuals at 8 years, of
which 6833 provided data for depressive symptoms between 10
and 19 years. IL-6 and CRP were measured on 5076 participants
at age 9 years, of which 4409 provided data for depressive symp-
toms between 10 and 19 years. We excluded 491 children who
reported an infection around blood collection from the analyses
of inflammatory markers because IL6 and CRP levels sharply
increase during an infection, which return to normal after illness
subsides; we were interested in inflammatory marker levels in
healthy individuals.
Ethical approval
Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics
Committees.
Laboratory methods
Data on two archetypal circulating markers of inflammation, CRP
(an acute phase protein) and IL-6 (a pleotropic, inflammatory
cytokine), were available from the ALSPAC birth cohort. At age
9 years non-fasting blood samples were collected by venepunc-
ture; samples were immediately spun and frozen at −80 °C after
collection. IL-6 and CRP levels were assayed in 2008 after a
median of 7.5 years in storage with no previous freeze–thaw cycles
during this period. IL-6 was measured by enzyme-linked
immunosorbent assay (ELISA) (R&D systems, UK), and high sen-
sitivity CRP by automated particle-enhanced immunoturbidi-
metric assay (Roche UK). All inter-assay coefficients of
variation were <5%. In the total sample, IL-6 values ranged
from 0.007 to 20.051 pg/mL and CRP values ranged from 0.01
to 45.17 mg/L (32 subjects over 10 mg/L). No other inflammatory
markers were measured on blood samples collected at age 9 years.
Serum IL-6 and CRP levels were correlated; Pearson’s correlation
co-efficient based on natural log-transformed values of IL-6 and
CRP was 0.45; p < 0.001.
Psychiatric measures
Psychological and behavioural problems at age 7
Mothers completed the parental version of the Strengths and
Difficulties Questionnaire (SDQ) when the study child was
7. The SDQ is an age appropriate, valid and reliable tool for meas-
uring psychological and behavioural problems in young children
(Goodman, 1997). It measures difficulties in four domains (emo-
tional problems, conduct problems, hyperactivity, peer problems),
and gives a total difficulties score of 0–40.
IQ at age 8
Full scale, verbal and performance IQ were measured by the
Wechsler Intelligence Scale for Children, 3rd UK edition (WISC
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III) (Wechsler et al. 1992). A shortened version of the test was
applied by trained psychologists, whereby alternate items (always
starting with item number 1 in the standard form) were used for
all ten subtests with the exception of the coding subtest, which
was administered in its standard form. Used successfully in
other studies (Stricker et al. 1968; Finch & Chihldress, 1975;
Khandaker et al. 2014b), this method provides valid IQ measures
that show robust correlations with neurodevelopmental disorders,
neurocognitive measures, such as working memory, short-term
memory and sociodemographic factors such as social class
(Khandaker et al. 2014b).
Depressive symptoms between ages 10 and 19
Depressive symptoms were measured six times using the SMFQ
completed by the participants at ages 10, 13, 14, 17, 18 and 19
years (Angold et al. 1995). The SMFQ is a validated tool widely
used in epidemiological studies (Thapar & McGuffin, 1998;
Sharp et al. 2006), which includes 13 items covering core symp-
toms of depression and anxiety experienced in past 2 weeks.
Each item is scored zero (not true), one (sometimes true) or
two (true) giving a total score of 0–26. We defined individuals
with high depressive symptoms at each assessment using total
scores of 11 or above because such scores reflect potentially clin-
ically relevant symptom burden. Using this threshold the specifi-
city and sensitivity for a diagnosis of depression is 85 and 60%,
respectively (Angold et al. 1995), validated against the
Diagnostic Interview Schedule for Children (Costello et al. 1982).
Assessment of covariates
We included age, sex, father’s occupation, ethnicity, maternal
Edinburgh Post-natal Depression Scale (EPDS) score, SDQ total
difficulties score at age 7, total IQ score at age 8 and body mass
index (BMI) at age 9 as potential confounders. Age was recorded
at the time of assessment of IQ and inflammatory markers, which
was used as a continuous variable. Sex was recoded at birth and
was coded as a binary variable. Father’s occupation was recorded
at birth according to the UK Office of National Statistics
Classification System (Class I = professionals and higher man-
agerial workers; II = intermediate occupations; IIIa = skilled non-
manual occupations; IIIb= skilled manual occupations; IV =
partly skilled occupations; V = unskilled occupations), and was
coded as a categorical variable (non-manual, i.e. I + II + IIIa, v.
manual occupations, i.e. IIIb + IV + V). Ethnicity was recorded
at birth and was coded as a categorical variable (White v.
Others). Maternal depression was measured by EPDS at 8-week
post-partum and was used as a continuous variable. BMI was
recoded at age 9 years at the time of blood collection, which
was calculated as weight in kilogram divided by height in metre
squared. See above for descriptions of IQ and SDQ.
Statistical analysis
Latent class analysis (LCA) and baseline comparisons
LCA was used to identify classes or population sub-groups based
on six longitudinal assessments of depressive symptoms between
10 and 19 years (Collins & Lanza, 2010). Total SMFQ scores from
each wave of follow-up were coded as a binary variable using
score 11 as cut-off because we were interested in the association
between childhood biomarkers and subsequent population sub-
groups demarcated by potentially clinically relevant depressive
symptom burden. Bayesian information criterion (BIC) was
used to assess whether a two, three, or four class model provided
a better fit for the data (Schwarz, 1978); the best-fitting model is
the one with the lowest BIC. LCA is the stochastic model, so each
person does not belong to a class with 100% probability, unlike
for example in cluster analysis, rather each person is assigned to
the population sub-group they are most likely to belong. We
examined the relationship between population sub-groups of
depressive symptoms and known sociodemographic and other
correlates of depression at baseline. Baseline comparisons for IQ
were carried out using linear regression to calculate mean differ-
ence (95% CI) in full scale, verbal and performance IQ between
groups.
Association between persistent depressive symptoms and IQ,
IL-6 and CRP
We used multinomial logistic regression to calculate odds ratios
(OR) for persistent and adolescent-onset depressive symptoms,
compared with no symptoms, per S.D. increase in IL-6 levels at
baseline. First, we report unadjusted ORs. Second, we report
ORs after adjusting for total IQ scores at age 8 years. This is
because we wanted to examine whether evidence for association
between IL-6 and persistent depressive symptoms remained
after taking into account general intelligence. Third, we report
ORs after adjusting for childhood psychological and behavioural
problems, i.e. SDQ total difficulties score at age 7 years.
Childhood psychological and behavioural problems are associated
with lower IQ (Horwood et al. 2008), higher levels of inflamma-
tory markers (Khandaker et al. 2014a), and increased risk of
depression and other psychiatric disorders subsequently in child-
hood and adulthood (Rutter et al. 2006). Therefore, we wanted to
examine whether evidence for association between IL-6 and per-
sistent depressive symptoms remained after taking into account
psychological and behavioural problems preceding the measure-
ment of IL-6. Finally, we report ORs after adjusting for all poten-
tial confounders, which are age, sex, father’s occupation, ethnicity,
maternal EPDS score, SDQ total difficulties score, total IQ and
BMI (see assessment of covariates for details). We followed the
same analytic approach when CRP and IQ were used as predictor.
To test whether childhood IQ and IL-6 were independent predic-
tors of subsequent depressive symptoms we controlled the multi-
nomial regression model of IQ for IL-6 and vice versa. Linearity of
association between IQ and persistent depressive symptoms was
tested by including a quadratic term (IQ2) in the regression mod-
els; the same approach was used for IL-6 using IL-62 as quadratic
term.
Effect of initial depressive symptom level
Population sub-groups identified by LCA reflect initial differences
in depressive symptom severity at age 10 years as well as the sub-
sequent course until age 19 years. To test whether any association
with inflammation and IQ pertain to initial difference in symp-
tom severity or subsequent course of depressive symptoms, we
controlled multinomial logistic regression models for total
SMFQ score at 10 years.
Relationship between IQ and inflammatory markers
Linear regression examined the relationship between total IQ and
serum IL-6, CRP levels using natural log-transformed values for
the inflammatory markers which were normally distributed. We
calculated the beta-coefficient and 95% confidence interval for
change in serum inflammatory marker levels, in standard devi-
ation, for each standard deviation increase in IQ. Regression
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models were adjusted for age at blood collection, sex, social class
and ethnicity.
Moderating and mediating effect of IL-6
We tested for any interaction between IQ and IL-6 by including
an interaction term (IQxIL-6) in multinomial logistic regression
models using IQ and IL-6 as predictor and persistent depressive
symptoms as outcome. We also examined whether IL-6 levels at
9 years mediated the relationship between IQ at 8 years and per-
sistent depressive symptoms at 10–19 years based on sample with
data on all three variables. Mediation analysis was carried out
using logistic regression (MPlus software); persistent depressive
symptoms was used as outcome (binary variable), IQ was used
as predictor (continuous variable), and IL-6 was used as mediator
(continuous variable). The analyses compared persistent depres-
sive symptoms with no symptoms; participants with
adolescent-onset symptoms were excluded. We calculated regres-
sion co-efficient and standard error for direct and indirect effect
of IQ on risk of persistent depressive symptoms. Presence of a sig-
nificant indirect effect would indicate mediation of association
between IQ and persistent depressive symptoms by IL-6.
Sex difference
We examined whether sex differences applied to the association
between the adolescent depressive sub-groups and childhood bio-
markers. First, we calculated the ORs for persistent depressive
symptoms for each childhood biomarker separately for two
sexes using multinomial regression as above. Second, we included
a sex × biomarker (separately for IQ and IL-6) interaction term in
the multinomial regression models based on total sample.
Results
Population sub-groups of depressive symptoms between 10
and 19 years
Total SMFQ score and the percentage of subjects with a high bur-
den of depressive symptoms (total SMFQ score 11 or above)
increased with age between 10 and 19 years (Table 1).
After latent class analysis of longitudinal data from 9156 par-
ticipants a three class model was chosen based on the BIC (Fig. 1).
These groups were driven by the probability of high depressive
symptoms, defined as SMFQ score 11 or above, at the six
follow-up points. The BIC for a two latent class model was
22 582, for a three class model was 22 483, and for a four class
model was 22 500.
In the three-class model, class one had consistently low
depressive symptoms at all six follow-ups between 10 and 19
years (hereafter, ‘no symptoms’). In class two depressive symp-
toms were low in the first two follow-ups at 10 and 13 years
but increased subsequently (hereafter, ‘adolescent-onset symp-
toms’). Class three had consistently high depressive symptoms
at all six follow-ups (hereafter ‘persistent symptoms’). Therefore,
the groups represent individuals defined by consistently low levels
of depressive symptoms, occasionally high levels, and consistently
high levels of depressive symptoms.
Baseline sociodemographic characteristics and population
sub-groups of depressive symptoms
Sociodemographic characteristics, distributions of maternal EPDS
score at 8 weeks postpartum, SDQ score at age 7, IQ and inflam-
matory markers for the total sample have been presented in
Table 2. The population sub-groups of depressive symptoms dif-
fered significantly from each other in known sociodemographic
and other correlates of depression. Compared with the group
with no symptoms, the groups with depressive symptoms were
more likely to comprise women, had lower socio-economic back-
ground, higher SDQ score at 7 years, and higher maternal post-
natal depression score (Table 2).
Association between IQ at age 8 years and persistent
depressive symptoms from 10 to 19 years
Childhood IQ was associated with subsequent persistent (but not
adolescent-onset) depressive symptoms. The risk of being in the
persistent depressive symptoms group between 10 and 19 years
relative to the no symptoms group was 27% lower for each
1-S.D. increase in IQ at 8 years. After adjusting for potential con-
founders the association attenuated slightly, but evidence for an
association remained (Table 3; online Supplementary Fig. S1).
See online Supplementary Table S1 for fully adjusted model show-
ing ORs for each covariate. The quadratic term (IQ2) in the multi-
nomial regression model was not significant ( p = 1.00) suggesting
a linear dose-response relationship between childhood IQ and
subsequent persistent depressive symptoms. The association
between IQ and persistent depressive symptoms remained signifi-
cant after controlling for IL-6, and vice versa (see Tables 3 and 4),
suggesting that IQ and IL-6 are independent predictors of subse-
quent persistent depressive symptoms.
Table 1. Total SMFQ Score between ages 10 and 19 years in the ALSPAC cohort
Age at assessment (years) Total no. SMFQ score 11 or above, no. (%)
SMFQ median (IQR)
All subjects Male Female p valuea
10 7367 441 (6.0) 3 (1–6) 3 (2–6) 3 (1–6) <0.001
13 6682 472 (5.2) 3 (1–5) 3 (1–5) 3 (1–6) <0.001
14 6020 703 (11.7) 4 (2–7) 3 (1–6) 4 (2–8) <0.001
17 4994 902 (18.1) 4 (2–8) 3 (1–6) 5 (2–10) <0.001
18 4493 973 (21.7) 5 (3–10) 4 (2–8) 6 (3–11) <0.001
19 3332 730 (21.9) 5 (2–10) 4 (2–7) 6 (3–11) <0.001
aIndependent sample Kruskal–Wallis test used to compare distribution of SMFQ scores between male and female groups.
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Fig. 1. Three Class Model of Depressive Symptoms between 10 and 19 years in the ALSPAC cohort. Note: Class membership is driven by the probability of high
depressive symptoms, defined as total SMFQ score 11 or above, at six follow-up points. Class 1 = consistently low symptoms at all six follow-ups (‘No symptoms’).
Class 2 = symptoms low in the first two follow-ups but increase subsequently (‘Adolescent-onset symptoms’). Class 3 = consistently high symptoms at all six follow-
ups (‘Persistent symptoms’).
Table 2. Sociodemographic and other correlates of depressive symptoms
Characteristic Total Sample
Population sub-groups of depressive symptoms between 10 and 19 years
p ValueaNo symptoms Adolescent-onset symptoms Persistent symptoms
Total no. (%) 9156 (100) 7430 (81.2) 1213 (13.2) 513 (5.6) –
Male sex, no. (%) 4411 (48.2) 3871 (52.1) 363 (29.9) 177 (34.5) <0.0001
British White, no. (%) 8059 (97.9) 6534 (97.9) 1077 (98.1) 448 (98.0) 0.92
Father’s non-manual occupation, no. (%) 4527 (49.4) 3713 (60.6) 596 (59.4) 218 (53.0) 0.009
Mother’s EPDS score, mean (S.D.) 5.89 (4.65) 5.7 (4.60) 6.5 (4.82) 7.0 (4.77) <0.0001
SDQ total score at age 7 years, mean (S.D.) 7.40 (4.75) 7.2 (4.62) 8.1 (4.99) 9.4 (5.55) <0.0001
Age at IL-6/CRP assay, mean (S.D.) (days) 3616 (115.6) 3617 (115.1) 3612 (117.3) 3622 (118.9) 0.27
BMI at IL-6 and CRP assay, mean (S.D.) 17.7 (2.90) 17.6 (2.84) 17.9 (3.10) 18.0 (3.23) 0.003
IQ at 8 years
Total no. (%) 6833 (100) 5578 (81.6) 862 (12.6) 393 (5.75) –
Full scale IQ, mean (S.D.) 104.63 (16.38) 105.02 (16.40) 104.19 (15.51) 100.09 (17.25) <0.0001
Verbal IQ, mean (S.D.) 107.57 (16.71) 107.97 (16.78) 107.02 (16.65) 102.90 (17.28) <0.0001
Performance IQ, mean (S.D.) 100.02 (16.99) 100.30 (16.98) 99.96 (16.36) 96.53 (18.04) <0.0001
Serum IL-6 at 9 years (pg/mL)
Total no. (%) 4409 (100) 3584 (81.28) 559 (12.67) 266 (6.03) –
Mean (S.D.) 1.18 (1.42) 1.25 (1.49) 1.48 (2.02) 0.005
Median (IQR) 0.76 (0.47–1.31) 0.80 (0.48–1.46) 0.89 (0.55–1.56) 0.017
Serum CRP at 9 years (mg/L)
Total no. (%) 4417 (100) 3592 (81.32) 559 (12.65) 266 (6.02) –
Mean (S.D.) 0.58 (1.68) 0.77 (3.00) 0.75 (1.84) 0.053
Median (IQR) 0.20 (0.11–0.47) 0.21 (0.11–0.48) 0.26 (0.12–0.59) 0.045
S.D., standard deviation; SDQ, Strengths and Difficulties Questionnaire ; BMI, body mass index; IQR, interquartile range; pg/mL, picogram per millilitre; mg/L, milligram per litre.
aOne way analysis of variance for continuous data (age, mother’s depression score, SDQ score, body mass index and mean values of IQ, IL-6 and CRP); Chi-squared test for proportions (male
sex, British White ethnicity and father’s occupation); independent samples Kruskal–Wallis test for IL-6 and CRP distributions (median).
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Association between IL-6 and CRP levels at age 9 years and
persistent depressive symptoms from 10 to 19 years
Higher IL-6 levels at 9 years were associated with subsequent per-
sistent depressive symptoms between 10 and 19 years. The adjusted
OR for being in the persistent depressive symptoms group relative to
the no symptoms group for each 1-S.D. increase in IL-6 levels was
1.20 (95% CI, 1.03–1.39) (Table 4; online Supplementary Fig. S1).
The quadratic term (IL-62) in the multinomial regression model
was not significant ( p = 0.80) suggesting a linear dose–response
relationship between childhood IL-6 levels and subsequent persist-
ent depressive symptoms. There was no evidence for an association
between CRP and persistent depressive symptoms. See online
Supplementary Tables S2 and S3 for fully adjusted models for
IL-6 and CRP showing ORs for each covariate.
Effect of psychological and behavioural problems at age 7 years
Evidence of associations between childhood IQ at 8 years, IL-6 at
9 years and subsequent persistent depressive symptoms at 10–19
years all persisted after adjusting for SDQ score at age 7 (Tables 3
and 4), suggesting that the associations between persistent
depressive symptoms, childhood IQ and IL-6 levels were inde-
pendent of the effect of past psychological and behavioural pro-
blems on these biomarkers.
Effect of initial depressive symptom level at age 10 years
The OR for persistent depressive symptoms between 10 and 19
years for childhood IL-6 at 9 years remained significant after con-
trolling for total SMFQ score at 10 years; adjusted OR = 1.16 (95%
CI, 1.03–1.31); p = 0.018. This suggests that childhood IL-6 levels
at 9 years predict the course of depressive symptoms between 10
and 19 years independently of initial symptom severity at age 10
years. However, the OR for persistent depressive symptoms from
10 to 19 years for childhood IQ at 8 years became non-significant
after controlling for total SMFQ score at 10 years; adjusted OR =
0.95 (95% CI, 0.85–1.08); p = 0.484.
Association between total IQ and serum IL-6, CRP level
Higher total IQ scores at age 8 years were associated with lower
serum CRP levels at age 9 years; β =−0.071 (95% CI, −1.00,
Table 3. ORs for persistent and adolescent-onset depressive symptoms between 10 and 19 years for each S.D. increase in total IQ score at age 8 years
Group No. (%)
OR (95% CI)
Unadjusted
analysis
Adjusted for IL-6
levels at 9 years
only
Adjusted for SDQ
total difficulties
score at 7 years only
Adjusted for age at IQ assessment, sex,
father’s occupation, ethnicity, maternal
EPDS score, SDQ total difficulties score
and IL-6 levela
No symptoms 5578 (81.6) 1.00 [reference] 1.00 [reference] 1.00 [reference] 1.00 [reference]
Adolescent-onset
symptoms
862 (12.6) 0.95 (0.88–1.02) 0.94 (0.86–1.04) 0.98 (0.90–1.06) 0.97 (0.87–1.09)
Persistent
symptoms
393 (5.8) 0.73 (0.66–0.81) 0.70 (0.61–0.80) 0.83 (0.73–0.93) 0.80 (0.68–0.95)
aAnalysis was controlled for age at assessment of IQ, sex at birth, father’s occupational status at birth, ethnicity at birth, maternal Edinburgh Post-natal Depression Scale (EPDS) total score
at 8-week post-partum, Strengths and Difficulties Questionnaire (SDQ) total difficulties score at age 7 years, serum IL-6 concentration at age 9 years. Please see section ‘assessment of
covariates’ for more information.
Table 4. ORs for Persistent and adolescent-onset depressive symptoms between 10 and 19 years for each S.D. increase in IL-6, CRP at age 9 years
Group No. (%)
OR (95% CI)
Unadjusted
analysis
Adjusted for
total IQ score at
8 years only
Adjusted for SDQ
total difficulties
score at 7 years
only
Adjusted for age at IL-6
assessment, sex, father’s
occupation, ethnicity, maternal
EPDS score, SDQ total difficulties
score, IQ, BMI at 9 yearsa
Predictor: per S.D. increase in serum IL-6 at 9 years
No symptoms 3584 (81.3) 1.00 [reference] 1.00 [reference] 1.00 [reference] 1.00 [reference]
Adolescent-onset symptoms 559 (12.7) 1.05 (0.96–1.15) 1.03 (0.93–1.14) 1.08 (0.98–1.20) 1.08 (0.95–1.22)
Persistent symptoms 266 (6.0) 1.18 (1.06–1.31) 1.16 (1.04–1.30) 1.17 (1.04–1.33) 1.20 (1.03–1.39)
Predictor: per S.D. increase in serum CRP at 9 years
No symptoms 3592 (81.3) 1.00 [reference] 1.00 [reference] 1.00 [reference] 1.00 [reference]
Adolescent-onset symptoms 559 (12.7) 1.11 (1.01–1.23) 1.09 (0.97–1.23) 1.11 (1.01–1.24) 1.14 (0.97–1.34)
Persistent symptoms 266 (6.0) 1.10 (0.96–1.27) 1.08 (0.91–1.27) 1.09 (0.93–1.26) 1.16 (0.95–1.43)
aAnalysis was controlled for age at assessment of IL-6, sex at birth, father’s occupational status at birth, ethnicity at birth, maternal Edinburgh Post-natal Depression Scale (EPDS) total score
at 8-week post-partum, Strengths and Difficulties Questionnaire (SDQ) total difficulties score at age 7 years, total IQ score at 8 years, and BMI at age 9 years. Please see section ‘assessment of
covariates’ for more information.
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−0.041); p < 0.001. Evidence for this association remained after
adjusting for age, sex, father’s occupation and ethnicity; adjusted
β = −0.048 (95% CI, −0.080, −0.016); p = 0.003. Similarly, higher
total IQ scores at age 8 years was associated with lower serum IL-6
levels at age 9 years; β =−0.046 (95% CI, −0.077, −0.015); p =
0.004. However, this association was attenuated after adjusting
for age, sex, father’s occupation and ethnicity; adjusted β =
−0.024 (95% CI, −0.050, 0.010); p = 0.163.
Moderating and mediating effects of IL-6 on the IQ-persistent
depressive symptoms relationship
There was no evidence for any interaction between IQ and IL-6 in
relation to risk of persistent depressive symptoms ( p value for
interaction term = 0.149). With regards to results of mediation
analysis, based on 3350 participants the direct effect of IQ on per-
sistent depressive symptoms was significant indicating an associ-
ation between IQ and persistent depressive symptoms; regression
coefficient for direct effect = −0.188, S.E. = 0.037; p < 0.001.
However, there was no evidence that IL-6 at 9 years mediated
the relationship between IQ at 8 years and persistent depressive
symptoms between 10 and 19 years; regression co-efficient for
indirect effect =−0.004, S.E. = 0.002; p = 0.073. The regression
coefficient for total effect (a sum of indirect and direct effect)
was −0.192, S.E. = 0.037; p < 0.001.
Sex difference in the association between IQ, IL-6 and
persistent depressive symptoms
In analyses stratified by sex, childhood IQ was associated with
subsequent persistent depressive symptoms in both sexes (see
online Supplementary Table S4). For IL-6, although the ORs
were similar between sexes that for men was no longer statistically
significant. However, no tests for interaction between IQ and sex
and IL-6 and sex in the respective regression models approached
statistical significance (both p > 0.10), suggesting no significant
sex difference in the overserved associations between IQ, IL-6
and persistent depressive symptoms.
Discussion
Using population-based longitudinal birth cohort data, we
defined a population sub-group of young people characterised
by persistent depressive symptoms during the second decade of
life. Lower IQ at 8 years, a measure of neurodevelopment, and
higher IL-6 at 9 years, a measure of inflammation, were independ-
ently associated with increased risk of subsequent persistent (but
not adolescent-onset) depressive symptoms between 10 and 19
years in a linear, dose–response fashion. Evidence for an associ-
ation persisted after controlling for a number of potential con-
founders including sex, body mass, social class, ethnicity,
maternal post-natal depression and psychological and behavioural
problems measured before the biomarkers at 7 years. To our
knowledge this is one of the first longitudinal studies of childhood
IQ, inflammatory markers and subsequent persistent depressive
symptoms. The results are consistent with potentially important
roles for inflammation and neurodevelopment in the aetiology
of persistent depressive symptoms, and indicate important differ-
ences between adolescent-onset and persistent depressive symp-
toms during the second decade of life.
Findings from the current study are consistent with previous
longitudinal studies reporting an association between adult
depression and lower IQ in childhood (van Os et al. 1997;
Zammit et al. 2004; Koenen et al. 2009). The results are also con-
sistent with previous longitudinal studies showing an association
between adult depression, higher IL-6 levels in childhood
(Khandaker et al. 2014a) and in adulthood (Zalli et al. 2016).
Poorer childhood IQ has been associated with increased risk of
adult schizophrenia (Jones et al. 1994; David et al. 1997;
Davidson et al. 1999; Cannon et al. 2000; Cannon et al. 2002;
Woodberry et al. 2008; Khandaker et al. 2011), post-traumatic
stress disorder (Koenen et al. 2007; Kremen et al. 2007), anxiety
(Koenen et al. 2009) and substance misuse disorders
(Mortensen et al. 2005). It has been suggested that general cogni-
tive ability as measured by IQ may be a marker of the integrity of
the nervous system (Whalley & Deary, 2001) and of cognitive
reserve (Barnett et al. 2006), which might underlie the association
between childhood IQ and subsequent risk of mental illness.
Association with lower IQ indicates a neurodevelopmental com-
ponent to depressive symptoms persistent during late childhood
and teenage years.
Accumulating evidence implicates the immune system, par-
ticularly low-grade systemic inflammation defined by elevated
concentrations of circulating inflammatory markers, in the patho-
genesis of depression, psychosis and other major mental disorders
(Raison et al. 2006; Dantzer et al. 2008; Khandaker et al. 2015).
CRP is an archetypal acute phase protein and IL-6 is a pleotropic
proinflammatory cytokine, both of which have been studied
extensively in depression and shown to be elevated in acutely
unwell patients compared with controls (Howren et al. 2009;
Haapakoski et al. 2015; Goldsmith et al. 2016). Longitudinal stud-
ies including our own have shown that elevated IL-6 or CRP levels
are associated with increased risks of developing depression and
psychosis in future (Gimeno et al. 2009; Wium-Andersen et al.
2014; Khandaker et al. 2014a; Metcalf et al. 2017). The current
study adds to the existing evidence by showing that childhood
IL-6 levels are associated with subsequent persistent depressive
symptoms, which might indicate that low-grade systemic inflam-
mation contribute to development and persistence of depressive
symptoms.
The current study is distinct from previous studies from the
ALSPAC birth cohort that have examined the relationship
between inflammation and psychiatric symptoms. Childhood
IL-6 levels at 9 years have been reported to be associated with ato-
pic disorders (Khandaker et al. 2014c), depressive and psychotic
symptoms assessed at 18 years (Khandaker et al. 2014a), and
hypomanic symptoms assessed at age 22 years (Hayes et al.
2016). Another study has reported association between serum
CRP levels and generalised anxiety disorder both assessed at age
15 years (Khandaker et al. 2016). None of the previous studies
concerned persistent depressive symptoms between ages 10 and
19.
The use of a general population birth cohort, relatively large
sample, and prospective assessments for depressive symptoms,
IQ and inflammatory markers are some of the strengths of the
study. Limitations include missing data. The number of respon-
dents with missing data for SMFQ increased in successive follow-
ups between 10 and 19 years. Only about 1700 participants com-
pleted the questionnaire at all six follow-up points, a group
unlikely to be representative of the general population.
Therefore, in order to avoid any bias from missing data we
included individuals who completed at least one out of six
SMFQ questionnaires between 10 and 19 years for the calculation
of latent classes. In constructing the latent classes of depressive
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symptoms we deliberately used dichotomised SMFQ scores at six
follow-up points as opposed to SMFQ total scores or item level
data. This is because we were interested in the evolution of clinic-
ally relevant depressive symptoms during critical period of brain
development; the threshold used to dichotomise SMFQ data (total
score 11 or above) has been reported to represent burden of
depressive symptoms that may be clinically relevant (Angold
et al. 1995).
We did not have any data on depression at the time of IQ or
IL-6 measurements at ages 8 and 9 years, respectively, so the pos-
sibility of reverse causality cannot be ruled out. It is plausible that
persistent depressive symptoms between ages 10 and 19 represent
continuation of depressive symptoms that started earlier in child-
hood before the assessment of the biomarkers. However, the
results remained significant after controlling for SDQ score at 7
years providing some reassurance that reverse causality is unlikely
to be the sole explanation for the observed results.
We acknowledge any diurnal variation in serum IL-6 and CRP
concentrations may not be adequately captured by non-fasting
blood samples (de Jager et al. 2009). However, the use of non-
fasting samples would increase measurement error likely to be
random in relation to the outcome. No other blood samples
from childhood or adolescence were available to examine long-
term within-individual consistency of inflammatory marker
levels. However, one study of healthy volunteers found no signifi-
cant changes in serum IL-6 levels over a 3-year period (Knudsen
et al. 2008). Similarly, a large meta-analysis of population-based
studies of coronary heart disease has found that values for CRP
are sufficiently stable over time (Danesh et al. 2004). There was
some evidence that higher IQ at baseline was associated with sub-
sequent lower inflammatory marker levels. However, an opposite
effect, i.e. inflammation influencing cognitive function in young
people, is also plausible. In future prospective studies with data
on inflammatory markers at baseline and cognitive function in
follow-up are needed to examine this hypothesis. Childhood
and adolescent infection/inflammation affect adolescent neurode-
velopment, which is further complicated by malnutrition (Galler
et al. 2017; John et al. 2017). While this is particularly relevant
for low and middle-income countries, and that serious malnutri-
tion is unlikely to be a major issue in a contemporary UK cohort,
in future studies should examine the relationship between inflam-
mation, nutrition and development.
In summary, we report one of the first longitudinal studies of
childhood IQ, inflammatory markers and subsequent persistent
depressive symptoms during the second decade of life. The find-
ings indicate important roles for two distinct biological processes,
inflammation and neurodevelopment, in the aetiology of persist-
ent depressive symptoms.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291717003038.
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